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I N T R O D U C T I O N
ATP-binding cassette (ABC) transporters use the energy 
of ATP binding and hydrolysis to power the active trans-
location of a broad range of substrates across biological 
membranes. Their basic architecture comprises two 
transmembrane domains (TMDs) that form the sub-
strate translocation pathway and two cytoplasmic nucle-
otide-binding domains (NBDs) that interact with ATP. 
For the highly conserved NBDs, a common mechanism 
has emerged wherein ATP binding to the canonical 
Walker motifs in one NBD recruits the signature se-
quence of the partner NBD to initiate dimerization of 
the two NBDs; ATP hydrolysis subsequently disrupts   
the dimer (for reviews see Higgins and Linton, 2004;   
Locher, 2009; Rees et al., 2009). In contrast, with regard 
to TMDs, which must serve diverse functions for differ-
ent  transporters,  the  molecular  determinants  of  the 
translocation pathway and the conformational changes 
associated with the transport cycle remain largely elu-
sive. Recent crystallographic studies, however, do provide 
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evidence for the long-suspected movement of TMDs   
alternating between the inward-facing and outward- 
facing configurations for each transport cycle (Ward   
et al., 2007; Khare et al., 2009).
CFTR, the culprit behind the inherited disease cystic 
fibrosis, is a unique member of the ABC superfamily in 
that its two TMDs, each containing six transmembrane 
segments (TMs) (Fig. 1 A), constitute an ion perme-
ation pathway for the passive Cl
 flow (Riordan et al., 
1989; Bear et al. 1992). In addition to the four ABC do-
mains, CFTR contains an intracellular regulatory do-
main (R domain) with multiple consensus sites, whose 
phosphorylation by PKA allows ATP to gate the channel 
(for reviews see Gadsby et al., 2006; Chen and Hwang, 
2008;  Hwang  and  Sheppard,  2009).  Extensive  func-
tional studies together with high-resolution structures 
of CFTR’s two NBDs have provided mechanistic insights 
into the functional role and possible conformational 
changes of NBDs in controlling CFTR gating. However, 
the molecular mechanism for the channel pore in TMDs 
is  not  well  understood,  despite  a  body  of  functional 
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Cystic fibrosis transmembrane conductance regulator (CFTR) is the only member of the adenosine triphosphate–
binding cassette (ABC) transporter superfamily that functions as a chloride channel. Previous work has suggested 
that the external side of the sixth transmembrane segment (TM6) plays an important role in governing chloride 
permeation, but the function of the internal side remains relatively obscure. Here, on a cysless background, we 
performed cysteine-scanning mutagenesis and modification to screen the entire TM6 with intracellularly applied 
thiol-specific methanethiosulfonate reagents. Single-channel amplitude was reduced in seven cysteine-substituted 
mutants, suggesting a role of these residues in maintaining the pore structure for normal ion permeation. The re-
activity pattern of differently charged reagents suggests that the cytoplasmic part of TM6 assumes a secondary 
structure of an  helix, and that reactive sites (341, 344, 345, 348, 352, and 353) reside in two neighboring faces of 
the helix. Although, as expected, modification by negatively charged reagents inhibits anion permeation, interest-
ingly, modification by positively charged reagents of cysteine thiolates on one face (344, 348, and 352) of the helix 
affects gating. For I344C and M348C, the open time was prolonged and the closed time was shortened after modi-
fication, suggesting that depositions of positive charges at these positions stabilize the open state but destabilize the 
closed state. For R352C, which exhibited reduced single-channel amplitude, modifications by two positively charged 
reagents with different chemical properties completely restored the single-channel amplitude but had distinct   
effects on both the open time and the closed time. These results corroborate the idea that a helix rotation of TM6, 
which has been proposed to be part of the molecular motions during transport cycles in other ABC transporters, 
is associated with gating of the CFTR pore.
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constricted region close to S341. Our data also support 
the notion that the internal part of TM6 (S341 to Q353) 
assumes a secondary structure of an  helix, and the re-
active sites reside in two adjacent faces of the helix.
Interestingly, although the negatively charged MTSES 
inhibits currents generated by these mutants through 
reducing the single-channel amplitude, the positively 
charged MTSET poses only slight influence on the sin-
gle-channel amplitude in most cases, except at position 
352, where the R-to-C mutation decreases the single-
channel amplitude; however, bringing back the positive 
charge with MTSET or 2-amino-ethyl MTS (MTSEA) re-
stores  the  conductance.  Surprisingly,  effects  on  both 
the open time and the closed time are found when posi-
tively charged MTS reagents are deposited into each of 
the three positions (344, 348, and 352) that line one 
face of the helix. These results suggest that these posi-
tions are involved in the gating conformations changes. 
By measuring the modification rate and its dependence 
on the membrane potential, we were able to deduce 
that residues 341, 344, and 345 are located deep in the 
membrane field and/or in the narrow region of the 
pore, whereas residues 348, 352, and 353 are positioned 
in the wide cytoplasmic end of the helix.
M AT E R I A L S   A N D   M E T H O D S
Mutagenesis, cell culture, and transient expression
An original cysless CFTR construct was provided by B. Reenstra 
(University of Pennsylvania, Philadelphia, PA). In this construct, 
16 cysteines were mutated to serines, and two cysteines (C590 and 
C592) to leucines. Subsequently, an additional V510A mutation 
was introduced to promote expression (Wang et al., 2007). A sin-
gle cysteine was then engineered into each position in TM6 on 
the  cysless/V510A  background  using  the  QuikChange  XL  kit 
(Agilent Technologies). Mutations were confirmed by direct DNA 
sequencing  (DNA  core;  University  of  Missouri)  of  the  cDNA.   
Because all of our studies were performed under this cysless/
V510A background, we will refer to this construct as our wild-type 
(WT) cysless control.
The Chinese hamster ovary cells were grown at 37°C in Dulbec-
co’s modified Eagle’s medium supplemented with 10% fetal bo-
vine serum. The cDNA constructs of CFTR were cotransfected 
with  pEGFP-C3  (Takara  Bio  Inc.)  encoding  green  fluorescent 
protein, using PolyFect transfection reagent (QIAGEN) accord-
ing to the manufacturer’s protocols. The transfected cells were 
plated on sterile glass chips in 35-mm tissue culture dishes and in-
cubated  at  27°C  for  2–5  d  before  electrophysiological  experi-
ments were performed.
Electrophysiology
Membrane currents were recorded in inside-out patch clamp con-
figuration at room temperature (22–24°C). Borosilicate capillary 
glass was pulled with a two-stage vertical puller (Narishige) and 
subsequently fire-polished with a homemade microforge, yielding 
a pipette resistance of 2–5 MΩ when filled with the pipette solu-
tion (in mM: 140 NMDG-Cl, 2 MgCl2, 5 CaCl2, and 10 HEPES, ad-
justed to pH 7.4 with NMDG). Glass chips with transfected cells 
grown on were placed into a chamber on the stage of an inverted 
microscope (Olympus). The chamber was continuously perfused, 
initially with the bath solution (in mM: 145 NaCl, 5 KCl, 2 MgCl2, 
studies demonstrating that mutations affect ion-perme-
ation properties (Linsdell et al., 1998; Mansoura et al., 
1998; McCarty and Zhang, 2001). Systematic cysteine-
scanning methodologies have been used successfully to 
explore the molecular determinants of the pore-forming 
domain for numerous ion channels (e.g., Wilson and 
Karlin, 1998; Engh and Maduke, 2005; Li et al., 2008), 
but this strategy has been limited to the application of 
thiol probes from the external side of CFTR probably 
due to technical challenges imposed by the 18 endoge-
nous cysteines present mostly in the cytoplasmic domains 
of CFTR. Among CFTR’s 12 TMs, TM6 has been studied 
most extensively. However, cysteine-scanning studies of 
TM6 by using externally applied thiol reagents have gen-
erated  conflicting  results  among  different  groups,  as 
summarized in Alexander et al. (2009).
Recent construction and successful functional expres-
sion of a CFTR construct with all endogenous cysteines 
substituted (cysless) have made it possible for cross-link-
ing (Cui et al., 2006; Mense et al., 2006) and cysteine-
scanning experiments (Alexander et al., 2009; Zhou   
et al., 2010). In the present study, we chose TM6 (residues 
330–335) as our first candidate for cysteine-scanning ex-
periments because nearly all previous work has impli-
cated this segment as one of the pore-forming domains 
(for  reviews  see  McCarty,  2000;  Dawson  et  al.,  2003;   
Linsdell, 2006). For example, the positively charged 
amino acids R334 and K335 have been shown to serve as 
potential surface charges to promote entry of anions 
into the outer mouth of the pore (Smith et al., 2001). 
Evidence has also been gathered that T338, located one 
helical turn cytoplasmic to R334 and K335, may face the 
pore as a cysteine residue placed at this position can not 
only be modified by methanethiosulfonate (MTS) re-
agents, but also titrated with external protons (Liu   
et al., 2004). This same position has been implicated by 
several  studies  using  various  strategies  as  the  narrow 
part of the pore as viewed from the extracellular end 
of the pore (Linsdell et al., 2000; McCarty and Zhang, 
2001; Alexander et al., 2009). Although mutations of 
several residues in TM6 intracellular to T338 do affect 
anion conductance and the affinity for CFTR blockers 
(for review see Linsdell, 2006), detailed understand-
ing of the cytoplasmic half of TM6 beyond position 
338 is limited.
Here, we engineered cysteine one at a time into   
TM6, applied, from the cytoplasmic side of the channel, 
positively  charged  2-trimethylammonium-ethyl  MTS 
(MTSET) and negatively charged 2-sulfonato-ethyl MTS 
(MTSES), and monitored in real time the current re-
sponse  to  these  reagents  in  excised  inside-out  mem-
brane patches. We found that both MTSET and MTSES 
can react with the cysteines introduced at six positions 
(S341, I344, V345, M348, R352, and Q353). The reactiv-
ity pattern is consistent with the idea that TM6 can be 
divided into internal and external parts connected by a   Bai et al. 295
MTS reagents was used, but the MTSES concentration was low-
ered to 50 µM (Fig. 11) for cysteine-substituted mutants with fast 
modification rates.
Two technical precautions were taken to ensure the quality of 
our data. First, spontaneous oxidation of the thiol group has been 
reported to protect the engineered cysteine from MTS modifica-
tion (Li et al., 2005; Liu et al., 2006). In theory, this reaction could 
happen during the activation phase of our experiments, as phos-
phorylation of the channels by PKA usually takes 3–10 min to 
reach a steady state. We therefore added 10 mM dithiothreitol 
(DTT; Sigma-Aldrich) into the solution containing PKA to ensure 
that the introduced cysteine is mostly in a reduced form. Second, 
because the presence of membrane-associated protein phospha-
tases in excised patches (e.g., Luo et al., 1998; Zhu et al., 1999) 
could give rise to false positive hits when a decrease of the current 
is used as a marker, all MTS reagents were added after a stationary 
recording was established with ATP alone. An absence of current 
decrease with ATP alone ensures that the observed reduction of 
the  current  upon  the  addition  of  the  MTS  reagent  is  indeed 
caused by modification of the introduced cysteine.
1 CaCl2, 5 glucose, 5 HEPES, and 20 sucrose, adjusted to pH 7.4 
with NaOH), and later on with the standard perfusate (in mM: 
150 NMDG-Cl, 10 EGTA, 10 HEPES, 8 Tris, and 2 MgCl2, adjusted 
to pH 7.4 with NMDG). Patches with seal resistances of >40 GΩ 
were excised for further experiments. Current signals at 50 mV 
membrane potential (unless specified otherwise) were acquired 
with a patch clamp amplifier (EPC10; HEKA), filtered at 100 Hz 
with an eight-pole Bessel filter (Warner Instruments), digitized 
online at 500 Hz with Pulse software (V8.80; HEKA), and cap-
tured onto a hard disk. Fast solution exchange was achieved using 
a solution exchange system (SF-77B; Warner Instruments), which 
can minimize the delay in the solution exchange to 30 ms as de-
termined previously (Tsai et al., 2009).
Cysteine modification
MTS reagents (MTSES, MTSET, and MTSEA; Toronto Research 
Chemicals  Inc.)  were  prepared  as  100-mM  stock  solutions  in 
ddH2O stored at 70°C. Immediately before use, a single aliquot 
of the stock solution was thawed into the perfusion solution con-
taining 2 mM ATP. In most cases (Figs. 1 and 3–10), 1 mM of the 
Figure 1.  Cysless CFTR is an appropri-
ate background for cysteine scanning. 
(A)  Topological  diagram  of  CFTR 
showing  its  domain  architecture:  two 
TMDs, two NBDs, and one R domain. 
Each TMD contains six TMs (1–6 and 
7–12)  connected  by  intracellular  and 
extracellular  loops.  Cysteines  were 
introduced  into  TM6  (yellow).  The 
sequence  of  TM6  is  shown,  and  resi-
dues where cysteine-substitution affects 
single-channel amplitude are indicated 
by  stars.  (B  and  C)  Modification  of 
phosphorylated WT CFTR channels by 
MTSET and MTSES. After the ATP-in-
duced current reached a plateau, the 
solution was exchanged from ATP to 
ATP plus MTSES or MTSET using the 
fast solution exchange system (see Ma-
terials and methods). The solution was 
switched back to ATP after the MTS re-
agents took full effect. The dotted line   
represents  the  baseline  in  all  figures. 
(D and E) Similar protocols as in B and C   
showing that cysless CFTR channels do 
not respond to the treatment of MTS.296 TM6 involved in gating motion of CFTR
activity was decreased by fivefold during exposure to   
1 mM MTSES, a negatively charged MTS reagent, and 
remained at the decreased level after removal of the re-
agents. In contrast, 1 mM MTSET, a positively charged 
MTS reagent, modestly increased the WT channel cur-
rent (Fig. 1 C). To generate the background required 
for our studies, we made a cysless CFTR construct by 
mutating all endogenous cysteines (see Materials and 
methods for details). Macroscopic currents from cysless 
CFTR could be similarly elicited by ATP as WT channels 
but were insensitive to cytoplasmic-applied MTSES or 
MTSET (Fig. 1, D and E). Moreover, the single-channel 
current amplitude of cysless CFTR is only slightly al-
tered (not depicted), similar to previous reports (Cui   
et al., 2006; Mense et al., 2006). Overall, these proper-
ties of this cysless (or cysless/WT) CFTR make it an   
appropriate background for assessing the reactivity of sub-
sequently  introduced  cysteines  in  TMDs  of  CFTR  with 
thiol-modifying reagents.
Reactivity of substituted cysteines in TM6 to MTS reagents
We  introduced  cysteines,  one  at  a  time,  throughout 
TM6 (residues 330–354) on the cysless/WT construct. 
The  effects  of  cysteine  substitution  on  anion  perme-
ation can be first inferred from the change in the single-
channel current amplitude. 7 out of the 25 mutant 
channels  exhibited  a  reduced  single-channel  current 
amplitude, including, from extracellular to intracellu-
lar, R334C, K335C, F337C, T338C, S341C, R347C, and 
R352C (Fig. 2). The single-channel amplitude is unsolv-
able in the cases of R334C, S341C, R347C, and R352C 
due to a limited bandwidth, whereas it is 0.2–0.3 pA for 
Data analysis
Current  traces  containing  fewer  than  three  channel  opening   
levels  and  lasting  for  >1  min  were  selected  for  single-channel   
kinetic analysis using a program developed by L. Csanády (2000).   
A three-state kinetic model, C↔O↔B, was adopted to extract gat-
ing parameters (open time, closed time, and Po) as described 
previously (Bompadre et al., 2005). Single-channel amplitude was 
estimated by Gaussian fitting of the all-point amplitude histo-
gram with the multi-peak fitting package in the Igor Pro program 
(V4.07; WaveMetrics).
For  the  modification  of  MTSES,  the  apparent  second-order   
reaction rate constant was calculated as 1/( × [MTSES]), where 
 was measured by fitting the current decay phase upon the addi-
tion of MTSES with a single-exponential function.
All results were presented as means ± SEM; n represents the 
number  of  experiments.  Student’s  paired  or  unpaired  t  test 
(two-tailed) was performed with Excel 2007. P < 0.05 was consid-
ered significant.
R E S U LT S
Cytoplasmically applied MTS reagents alter the channel 
function of WT CFTR, but not cysless CFTR
A construct that shows little response toward thiol- 
modifying reagents is a prerequisite for cysteine-scanning 
studies.  However,  there  are  18  endogenous  cysteines 
scattering through all five domains of the WT CFTR 
protein. Reactivity of one or several of these cysteines 
toward MTS reagents was observed when the reagents 
were applied to the cytoplasmic side of inside-out mem-
brane patches containing WT CFTR channels, which 
were first activated to a steady state with the catalytic 
subunit of PKA plus 2 mM ATP. An example of the ex-
periments was shown in Fig. 1 B. ATP-induced channel 
Figure  2.  Effects  of  cysteine 
substitutions  on  single-channel 
current  amplitude.  (A)  Single-
channel  traces  for  cysless/WT 
and two cysteine-substituted mu-
tants. Single-channel amplitude: 
cysless/WT, 0.46 ± 0.005 pA (n = 5);   
cysless/K355C, 0.28 ± 0.011 pA 
(n  =  4);  cysless/F337C,  0.19  ± 
0.008 pA (n = 3). (B) Summary of 
the single-channel amplitude for 
cysless/WT and all mutant chan-
nels. The data are shown as mean 
and SEM of three to seven exper-
iments. Stars indicate a significant 
difference  in  the  single-channel 
amplitude  from  the  cysless/WT, 
as determined by Student’s t test. 
Daggers indicate channels whose 
single-channel  amplitude  is  too 
small and/or variable to be mea-
sured accurately.  Bai et al. 297
applied from the external side, it can be inferred that 
there is a barrier around position 341 restricting the   
accessibility of the bulky MTS reagents applied from the 
cytoplasmic side.
Cytoplasmic  to  position  341,  the  reactive  cysteines 
can be divided into three categories based on the pat-
tern of their reactivity toward the two reagents. Repre-
sentative traces of each category are shown in Fig. 4. 
The first category (e.g., Fig. 4, A and B), in which negli-
gible effects were observed with either reagent, includes 
cysteines  introduced  at  positions  342,  343,  346,  347, 
349, 350, 351, and 354. Although the simplest inter-
pretation of these results is that these positions are not 
accessible to MTS reagents, it cannot be ruled out that 
they were modified but without significant effects on 
channel function. Cysteines falling into the second cat-
egory (344, 348, and 352) were reactive toward both   
reagents with charge-dependent functional effects. Spe-
cifically, the macroscopic current was enhanced after 
the application of the positively charged MTSET, but 
was attenuated in response to the negatively charged 
MTSES (Fig. 4, C and D). Spontaneous ATP-indepen-
dent  gating  of  cysless/I344C  and  cysless/M348C  was 
also increased by MTSET because after the removal   
of ATP, there remained a substantial amount of cur-
rent, which can be inhibited by CFTR-specific inhibitor, 
K335C, F337, and T338C at 50 mV membrane poten-
tial (0.46 pA for cysless/WT). Exact structural interpre-
tations  of  these  effects  are  difficult  without  further 
characterization of the functions of these mutant chan-
nels, but it has been proposed that this alteration of the 
single-channel conductance could be due to neutraliza-
tion of the fixed charge that serves to attract anions into 
the outer mouth of the pore (e.g., R334; Smith et al., 
2001), disruption of a salt bridge formed between posi-
tively charged residues in TM6 and negatively charged 
ones in other TMs (e.g., R347; Cotten and Welsh, 1999), 
or removal of a potential Cl
-binding site (e.g., S341; 
McDonough et al., 1994).
We then studied the reactivity of each of the substi-
tuted cysteines toward intracellularly applied charged 
MTS reagents. After the channels were activated with 
PKA and ATP, 1 mM MTSES or MTSET was applied in 
the presence of ATP until a steady state arrived. The 
ATP-induced currents before and after the treatment 
were compared. The results of these experiments are 
summarized in Fig. 3. None of the cysteines engineered 
at  positions  located  extracellularly  to  position  341   
appeared to react with the reagents. Because previous 
studies (Smith et al., 2001; Beck et al., 2008; Alexander 
et al., 2009) have shown that cysteines placed at some of 
these positions are reactive toward the same reagents 
Figure 3.  Summary of the change in macroscopic mean currents after modification. The percentage change in the mean current is 
calculated as (I/I01) × 100%, where I0 and I are the mean current before and after modification, respectively. The left column is the 
effect of MTSES (red), and the right is the effect of MTSET (blue). n = 3–8 for each construct. Stars indicate mutant channels exhibiting 
a reduced single-channel amplitude.298 TM6 involved in gating motion of CFTR
352)  are  particularly  intriguing  because  the  currents 
were increased by MTSET modification. Although the 
arginine at position 352 is a charged residue and con-
verting this R to C did change the single-channel ampli-
tude, this is not the case for residues 344 and 348 (Fig. 2). 
In addition, MTSET modification can more than dou-
ble the current in M348C channels. Therefore, it seems 
unlikely that this effect of modification is caused solely 
by a change of the single-channel conductance. We re-
sorted to single-channel recordings and performed all-
point histogram and gating kinetics analysis to further 
examine the effects of MTSET modification. A repre-
sentative  result  of  the  experiments  with  the  cysless/
M348C construct is shown in Fig. 5. In the presence of 
ATP, the cysteine-substituted channel exhibited a simi-
lar single-channel amplitude (Fig. 2 B) but a lower open 
probability (Po = 0.24 ± 0.03; n = 5) compared with the 
cysless/WT channel (0.64 ± 0.02; n = 5; Fig. 5, A and B). 
Upon the application of the positively charged MTSET, 
channel gating behavior was profoundly altered (Fig. 5, 
A and B). Both the open time and opening rate were 
CFTRinh-172 (Ma et al., 2002). Cysteines introduced at 
the last three positions (341, 345, and 353) belong to 
the third category. Although MTSET posed small (<20% 
for  S341C)  or  negligible  inhibition,  modification  by 
MTSES drastically reduced the current (e.g., Fig. 4,   
E and F). The observation that prior MTSET modifica-
tion effectively prevented the effect of MTSES indicates 
that cysteines 345 and 353 did react with MTSET. It is 
noted that cysteines in the second category (344, 348, 
and 352) are separated by three amino acids, and that 
cysteines in the third category (341, 345, and 353) fol-
low a similar pattern, with the exception of position 
349. These results are consistent with the idea that the 
cytoplasmic part of TM6 (from 341 to 354) assumes a 
secondary structure of an  helix.
Covalent modification of the cysteines substituted  
for M348 and I344 by positively charged MTSET  
increases the open probability (Po)
The charge-dependent functional effects of modifica-
tion of cysteines in the second category (344, 348, and 
Figure  4.  Three different patterns of func-
tional consequences after MTS modification. 
(A  and  B)  Neither  MTSES  nor  MTSET  al-
tered the current of cysless/T351C channels.   
(C)  Modification  of  348C  by  MTSES  de-
creased  the  current.  (D)  MTSET  increased 
ATP-dependent  current  in  cysless/M348C 
channels. After the removal of ATP, there re-
mained a large amount of ATP-independent 
current, which disappeared upon the applica-
tion of 10 µM CFTRinh-172. (E) MTSES re-
duced the current of cysless/Q353C channels.   
(F) For cysless/Q353C, the treatment of MTSET 
had little influence on channel function, but 
prevented the current decrease in response to 
MTSES, as in E.  Bai et al. 299
behavior and conduction properties were recovered after 
the application of 10 mM DTT.
Covalent modification by positively charged MTS reagents 
of the cysteine substituted for R352 not only restores Cl
 
conduction, but also alters channel gating
The results described above suggest that the side chains 
of the amino acid residues at positions 344 and 348 of 
TM6 are involved in the gating conformational changes. 
We further characterized the effects of modification of 
the cysteine substituted for the positively charged argi-
nine residue at the more cytoplasmic position 352, as 
this position is one helical turn intracellularly to posi-
tion 348. Some previous studies have suggested that this 
residue may serve to attract anions into the intracellular 
pore mouth via a “surface charge” effect (Aubin and 
Linsdell, 2006). Others provide evidence that it might 
form a salt bridge with residue D993 in TM9, and that 
neutralizing the positive charge at this position indi-
rectly affects anion conduction (Cui et al., 2008; Jordan 
et al., 2008). It has also been reported that charge- 
neutralizing mutation at this position would lead to fre-
quent transitions to subconductance states and rare 
transitions to full-conductance states (Cui et al., 2008). 
Fig. 7 depicts a representative recording of a patch con-
taining a single cysless/R352C CFTR channel. In the 
presence of ATP, the mutant channel opens to small 
visibly increased, resulting in a Po threefold higher than 
that before modification. Interestingly, MTSET modifi-
cation of M348C also slightly but significantly increased 
(12 ± 1%; n = 5) the single-channel amplitude (Fig. 5,   
A and C). The effects on both gating behavior and an-
ion conduction were readily reversed after the patches 
were exposed to 10 mM DTT, a commonly used reduc-
ing reagent (e.g., Liu et al., 2006; Reyes and Gadsby, 
2006). These results indicate that the effects of cysteine 
substitution as well as the subsequent modification by 
MTSET on Po are mainly through perturbing the con-
formational changes around this site of TM6 associated 
with gating (see Discussion for more details).
Effects  on  channel  gating  were  also  observed  with 
modification of the cysteine residue engineered into 
position 344, one helical turn extracellular to 348, as 
shown in Fig. 6. The mutant channel showed a similar 
Po (Fig. 6 B) and single-channel amplitude (Fig. 2 B)   
as the cysless/WT channel. However, modification by   
MTSET dramatically increased the open time, which was 
too long (on the order of tens of seconds) for collecting 
enough gating transitions for kinetics analysis. The Po 
was increased from 0.65 ± 0.02 (n = 7) to 0.92 ± 0.01   
(n = 7; Fig. 6 B) after modification. A minor effect on 
anion conduction after MTSET modification was also 
observed (Fig. 6 C); that is, the single-channel ampli-
tude was decreased by 5 ± 1% (n = 7). Again, gating 
Figure 5.  Effects of MTSET on 
a single cysless/M348C channel. 
(A) Single-channel traces in the 
presence  of  2  mM  ATP  before 
(left top trace) and after MTSET 
modification (left middle trace, 
blue), and after DTT treatment 
(left bottom trace) in the same 
patch.  Corresponding  all-point 
histograms (gray bars) and their 
Gaussian  fits  (black  and  blue 
lines)  were  plot  on  the  right.   
(B)  Gating  parameters  of  the 
cysless/M348C  channel  before 
(black) and after (blue) modi-
fication, as extracted from the 
traces in A. Those of the cysless/ 
WT  (gray)  in  the  presence  of   
2 mM ATP are also included for   
comparison (traces not depicted).   
n = 5 for cysless/M348C. n = 6 for 
cysless/WT.  (C)  Single-channel   
amplitude of the cysless/M348C 
channel before and after modifi-
cation in the same patch. Star in-
dicates significant difference as 
determined by Student’s paired 
t test; n = 5.300 TM6 involved in gating motion of CFTR
nearly three times that of MTSET-modified channel. The 
nearly identical effect on the single-channel amplitude 
but a distinct influence on gating by MTSET and MTSEA 
suggests that the arginine residue at position 352 plays 
two roles: first, the positive charge it bears does affect an-
ion permeation through the CFTR pore, and second, 
just like residues 344 and 348, this part of TM6 is likely 
involved in gating motion (see Discussion for details).
The  restoration  of  the  single-channel  amplitude  by   
MTSET or MTSEA on R352C compelled us to use an-
other strategy to assess the function of the CFTR pore be-
fore and after modification. Fig. 8 shows results obtained 
from patches yielding macroscopic cysless/R352C chan-
nel currents. The modification by MTSET increased the 
mean current by 40 ± 4.9% (n = 4; Fig. 8, A and C), whereas 
modification  by  MTSEA  increased  it  by  293  ±  28.5%   
(n = 6; Fig. 8, B and C). Because these two MTS reagents 
restored the single-channel amplitude to the same level, 
the distinct effects on the macroscopic mean current was 
due to their different effects on channel gating. To study 
the effects of modification on the pore structure, we ap-
plied an anionic pore blocker, glibenclamide (Sheppard 
and Robinson 1997; Zhou et al., 2002), before and after 
modification with MTSET or MTSEA. When the mem-
brane voltage was held at 50 mV, 50 µM glibenclamide 
induced 27.2 ± 1.7% (n = 10) block of the Cl
 current   
for  cysless/R352C.  Because  the  same  concentration  of 
and unsynchronized current levels (0.1–0.2 pA), differ-
ent from the fairly constant amplitude observed in the 
cysless/WT channel. But no full-conductance state was 
ever observed during minutes of recording, probably 
due to the limited bandwidth of our recording condi-
tion. The gating kinetics cannot be accurately deter-
mined because of the small and varying single-channel 
amplitude.  However,  when  R352C  was  modified  by   
MTSET, the single-channel amplitude was restored to 
that of the cysless/WT channel (Fig. 7 A). This effect of 
MTSET on the single-channel amplitude allows kinetic 
analysis of the modified channels (Fig. 7 B). Interest-
ingly, although bringing back the positive charge at this 
position  with  MTSET  completely  restores  the  single-
channel amplitude, gating of MTSET-modified cysless/
R352C is not fully recovered to the level of cysless/WT 
channels.  The  open  time  (0.29  ±  0.01  s;  n  =  5)  was 
shorter, and the closed time (1.9 ± 0.04 s; n = 5) was lon-
ger. In the same patch, after the MTSET adduct was re-
moved by DTT, MTSEA, another positively charged MTS 
reagent with an amine group different from that of   
MTSET,  also  restored  the  single-channel  amplitude. 
However, the gating behavior was different from that of 
channels modified by MTSET. The open time was signif-
icantly prolonged (0.49 ± 0.05 s; n = 7), and the closed 
time  was  also  shortened  considerably  (0.86  ±  0.12  s;   
n = 7), resulting in a Po of MTSEA-modified channel 
Figure  6.  A  single-channel  re-
cording of cysless/344C showing 
the  effect  of  MTSET.  (A)  Gat-
ing behavior in the presence of 
2 mM ATP before modification 
(left  top  trace),  after  modifica-
tion  (left  middle  trace,  blue), 
and  after  the  reversal  of  the 
modification  by  DTT  (left  bot-
tom  trace)  in  the  same  patch. 
Corresponding  all-point  his-
tograms  (gray  bars)  and  their 
Gaussian  fits  (black  and  blue 
lines)  were  plot  on  the  right. 
(B) The Po, obtained from the 
traces in A, of the cysless/I344C 
channel before (black) and after   
(blue)  modification.  Those  of 
the  cysless/WT  (gray)  in  the 
presence of 2 mM ATP are in-
cluded  for  comparison  (traces 
not depicted). n = 7 for cysless/
I344C.  n  =  6  for  cysless/WT.   
(C)  Single-channel  amplitude 
of  the  cysless/I344C  channel 
before  and  after  modification. 
Star  indicates  significant  differ-
ence as determined by Student’s 
paired t test; n = 7.  Bai et al. 301
can alter gating, it is unclear if the decrease of macro-
scopic current by MTSES for 341C, 344C, 345C, 348C, 
352C, and 353C was due to an effect on channel gating 
or anion permeation. Because anion conduction was se-
verely perturbed by the mutations R352C and S341C, 
we were not able to assess the effects of MTSES modifi-
cation on the single-channel amplitude for these two 
constructs. Instead, we will focus on the four other posi-
tive hits (i.e., I344C, V345C, M348C, and Q353C). Fig. 9 
depicts a sample experiment with the cysless/Q353C 
construct. After the channel was treated with MTSES, 
the single-channel amplitude was visibly decreased but 
cannot be quantified due to a large variation of the single-
channel current amplitude. The negatively charged   
adducts were hardly removable by the anionic DTT (not 
depicted),  probably  due  to  unfavorable  electrostatics 
between MTSES adduct and negatively charged reactive 
DTT as described by Alexander et al. (2009). For the 
positions 344, 345, and 348, however, single-channel   
recordings are not helpful because no visible current 
glibenclamide  at  the  same  holding  potential  induced 
stronger block in the cysless/WT channel (48.6 ± 3.0%;   
n = 5; Fig. 8 D), the effect of the blocker was attenuated by 
the R352C mutation. Bringing back the positive charge 
through modification by MTSET increased the fractional 
block to 44.1 ± 1.9% (n = 7; Fig. 8, A and D). Similarly, the 
modification by MTSEA increased it to 47.0 ± 1.6% (n = 6; 
Fig. 8, B and D). Thus, the blockade of the CFTR channel 
pore by glibenclamide relies in part on the positive charge 
at position 352. Collectively, we conclude that restoring 
the positive charge at this position confers a normal func-
tion of the pore in the context of chloride permeation and 
blockade of the pore by glibenclamide. However, the ef-
fect of charge-restoring modifications on gating depends 
on the specific chemical properties of the MTS reagents.
Covalent modification by negatively charged MTSES 
decreases Cl
 conduction
Although, as described above, modifications of 344C, 
348C, and 352C with positively charged MTS reagents 
Figure 7.  A single-channel recording 
showing that modification of 352C by 
MTSET  and  MTSEA  affects  both  Po 
and single-channel amplitude. (A; top 
trace)  A  continuous  recording  show-
ing  the  effects  of  MTSET  or  MTSEA 
on  a  single  cysless/R352C  channel. 
(Bottom traces) Expanded recordings 
for segments I–III marked in the top 
trace. A short part in segment I was fur-
ther zoomed out in a. Corresponding 
all-points  amplitude  histograms  of  II 
and III were depicted. Blue and green 
lines are the results of Gaussian fitting. 
(B)  Single-channel  amplitude,  Po, 
open time and closed time of MTSET- 
(blue)  and  MTSEA-modified  (green)   
cysless/R352C channel, as determined 
by Gaussian fitting and kinetics analy-
sis; n = 6.302 TM6 involved in gating motion of CFTR
inhibition of the macroscopic mean current (Fig. 4 C) 
and the single-channel current in the case of the cysless/
M348C channel might be due to oxidation of the intro-
duced cysteine to a state not reactive toward either DTT 
or MTS reagents. Similar oxidized states of cysteine thi-
olates engineered at position 338 that are not reversed 
by DTT were previously reported by Liu et al. (2006). 
Moreover,  whether  MTSES  also  affects  gating  is  un-
known because the small single-channel amplitude after 
modification precludes gating kinetics analysis.
Effects of membrane potential on the rate of  
MTSES modification
While inspecting the current changes upon the addi-
tion of MTSES, we noticed dramatic differences in the 
rate of current decay among different constructs. To 
further quantify the accessibility of engineered cyste-
ines to the intracellularly applied MTS reagents, we 
measured the modification rates of MTSES for engi-
neered cysteines at six positions with large functional 
effects. At a membrane potential of 50 mV, MTSES 
modified introduced cysteines at the more superficial 
fluctuation was seen after modification in patches yield-
ing microscopic currents (not depicted). This could be 
due to either an extremely small single-channel ampli-
tude or minimal opening probability. In a representa-
tive  recording  of  a  patch  containing  hundreds  of 
cysless/I344C channels (Fig. 10), one can clearly dis-
cern the single-channel amplitude from the expanded 
trace  before  and  after  phosphorylation-dependent 
activation.  Before  MTSES  modification,  these  single-
channel amplitudes are similar to that of the cysless/
WT channel (Fig. 2). After MTSES modification, a dra-
matic reduction of the macroscopic current occurred. 
Upon removal of ATP, a very smooth current relaxation 
reflecting  the  closing  of  individual  MTSES-modified 
channels was seen (Fig. 10, red expanded trace), indi-
cating  that  the  single  channel-amplitude  of  MTSES-
modified channels was too small to be resolved. Similar 
results were obtained with the cysless/V345C and cysless/
M348C channels. Thus, depositing negative charges 
at these three positions (344, 345, and 348) severely   
reduces anion conduction. Although the exact reason   
is unknown, the discrepancy between the extent of 
Figure  8.  Blocking  of  cysless/
R352C channels by glibenclamide 
before  and  after  MTS  modifica-
tion.  (A  and  B)  The  blocking  ef-
fect  of  50  µM  glibenclamide  was 
enhanced after the channels were 
modified by MTSET and MTSEA. 
(C)  Percentage  change  in  mean 
current induced by MTSET (blue) 
and MTSEA (green). (D) The frac-
tion of block, calculated as (1Ig/
I0) × 100% (Ig and I0 are the mean 
current in the presence of ATP and 
ATP  plus  glibenclamide,  respec-
tively),  for  cysless/WT  channels 
(gray),  cysless/R352C  channels 
before  modification  (black)  and 
after  modification  with  MTSET 
(blue), and after modification with   
MTSEA  (green).  Star  indicates  a 
significant difference from cysless/
WT channels.
Figure 9.  Modification of 353C by negatively 
charged MTSES reduced the single-channel 
amplitude.  This  representative  recording 
(among  five  patches)  contains  two  cysless/
Q353C  channels.  After  the  application  of 
MTSES,  the  single-channel  amplitude  was   
reduced. Segment a (red) is expanded to 
show the varying single-channel amplitude 
after modification.  Bai et al. 303
the membrane voltage was held at 100 mV was five 
times faster than that when it was at 50 mV. And it was 
even more rapid when the membrane potential was   
hyperpolarized to 150 mV (Fig. 11 C). Similar voltage-
dependent reaction rates were observed for modifica-
tion of 341C and 344C. The reaction rate was 10-fold 
faster at 150 mV than that at 50 mV. In contrast, the 
modification rates by 50 µM MTSES at 50 and 100 mV 
were not significantly different for 348C (Fig. 11 B). 
Similarly, the membrane potential had negligible effects 
on the modification rate for 352C and 353C. These data 
suggest that residues cytoplasmic to M348 do not reside 
in  the  electrical  field.  The  structural  implications  of 
these results will be discussed.
D I S C U S S I O N
Our  cysteine-scanning  study  on  TM6  under  a  cysless 
CFTR background reveals that this TM governs both 
gating and permeation properties of the channel pore. 
The reactivity of engineered cysteines to intracellularly 
applied probes suggests that part of TM6 (residues   
341–354) is exposed to the cytoplasm and assumes an 
-helical structure. Surprisingly, cysteine modification 
by positively charged probes had minimal influence 
positions 348 (9,076 ± 983 M
1s
1; n = 5) and 353 (2,715 ± 
646 M
1s
1; n = 4) rapidly (Fig. 11). However, although 
352C is also physically close to the cytoplasmic end, its 
modification rate is >100 times slower than that of 348C. 
The reason for this slow reaction rate is unclear, but it 
could be due to a perturbation of the pore architecture 
by the R352C mutation (Cui et al., 2008). For deeper 
positions, cysteine modification is rather slow: second-
order  reaction  rate  constants  are  596  ±  73  M
1s
1  
(n = 7), 20 ± 0.6 M
1s
1 (n = 3), and 6 ± 0.8 M
1s
1  
(n = 5) for 344C, 345C, and 341C, respectively. Com-
pared with the rate constant for MTSES reaction with 
free mercaptoethanol (17,000 M
1s
1; Karlin and Akabas, 
1998), these slow modification rates suggest that these 
positions (341, 344, 345, and 352) in TM6 are not read-
ily accessible to the MTS reagents. In other words, the 
accessibility of the MTS reagents might be restricted by 
physical or chemical barriers around these positions.
We reasoned that if the residue is located deep in the 
electric field and MTSES has to traverse significantly 
into the field to react with the engineered cysteine, the 
modification rate can be enhanced by hyperpolarizing 
the membrane potential. A representative experimen-
tal result with the cysless/V345C construct is shown in 
Fig. 11 A. The modification rate by 1 mM MTSES when 
Figure  10.  MTSES  decreased  single-
channel  amplitude  of  cysless/I344C 
channels.  (Top  trace)  A  continuous 
recoding from a patch containing hun-
dreds of channels first phosphorylated 
with PKA, ATP, and DTT (see Materi-
als and methods) until the current is 
steady. The current in the presence of 
ATP was dramatically reduced by the 
treatment of MTSES. (Bottom traces) 
Expansions of segments I–III marked in 
the top trace. Segment I shows sponta-
neous openings in the absence of ATP. 
Segments II and III show the current 
relaxation after the removal of ATP.304 TM6 involved in gating motion of CFTR
this  region  between  T338  and  S341  (Linsdell  et  al., 
2000; McCarty and Zhang, 2001), which divides TM6 
into intracellular and extracellular parts. Six positive 
hits (I331, L333, R334, K335, I336, and T338) were 
identified by external MTS reagents (Beck et al., 2008; 
Alexander  et  al.,  2009;  but  cf.  Fatehi  and  Linsdell, 
2008). It is difficult to explain this pattern of reactivity 
with a simple helix facing the pore, as cysteines intro-
duced into four contiguous positions react with bulky 
MTS reagents. Thus, either the external part of TM6 is 
not helical or is loosely packed so that all of these posi-
tions  can  be  exposed  to  the  aqueous  environment,   
although it cannot be ruled out that this part might   
be involved in a very large movement during the gating 
process so that these positions were modified in differ-
ent functional states. In contrast, the cytoplasmic-reactive 
on anion permeation in most cases, but dramatically   
affected the gating behavior for three positions that 
line on one face of the helix. In contrast, the modifica-
tion by negatively charged reagents strongly inhibited 
anion permeation.
Accessibility pattern and its implications on the secondary 
structure of TM6
Previous cysteine-scanning studies using externally ap-
plied probes (Beck et al., 2008; Alexander et al., 2009) 
suggest that T338 is the innermost position accessible 
to  impermeant  MTS  reagents  (compare  Fatehi  and 
Linsdell, 2008). Here, our results suggest that S341 is 
the outermost position that can be assessed by internal 
MTS reagents. Collectively, these findings are consis-
tent with the idea that TM6 has a constriction around 
Figure  11.  Reaction  rates  of  MTSES  mod-
ification  at  various  membrane  potentials.   
(A and B) Macroscopic recordings of cysless/
V345C and cysless/M348C showing modifica-
tion by 1 mM MTSES when the membrane po-
tential is held at 50 mV (left) and 100 mV 
(right). Red lines are the results of exponen-
tial fitting. Note that the time scales of the left 
and the right traces are the same. (C) Sum-
mary of the second-order reaction rate con-
stants at three different membrane potentials. 
n = 4–7 for each data point.  Bai et al. 305
TM6 moves during gating transitions
Perhaps the most intriguing finding in our studies is 
that modification by positively charged MTSET of cys-
teines on one face of the TM6 helix affects channel gat-
ing (Figs. 5, 6, and 7). For both 344C and 348C, MTSET 
adducts increased the open time, suggesting that the 
open state is stabilized. The closed time is also short-
ened as a result of modification for 348C, indicating 
that the closed state is destabilized. In the case of 352C, 
MTSET-modified channels and MTSEA-modified chan-
nels exhibit distinct open time and closed time, which 
again suggests that the stability of both the open state 
and the closed state is different for channels with different   
sites, S341, I344, V345, M348, R352, and Q353 (Fig. 3), 
can be nicely placed in two faces of a well-packed  helix   
if the insensitive position A349 is also included (Fig. 12 A).   
Interestingly, Alexander et al. (2009) applied [Ag(CN)2]
, 
a permeant thiol reagent, from the extracellular side 
and  obtained  similar  results  on  most  positions  as 
ours, with the exception of F342 and A349. We do not 
know the reason for this discrepancy, but the much 
smaller  size  of  [Ag(CN)2]
  may  allow  access  to  re-
gions that are too narrow for bulky MTS reagents. 
The same reason might as well explain why A349 is 
the singular insensitive site on these two faces in the 
present study.
Figure 12.  (A) Cartoons showing putative helical structures of part of TM6 (341–354). Structure of the cytoplasmic part of TM6 was 
published by Serohijos et al. (2008). Six reactive sites identified by this study were represented as colored sticks. Position 349, albeit not 
reactive (indicated by parentheses), was included for clarity. Figures were prepared with PyMOL (V0.99; Schrödinger). (B) A continuous 
single-channel recording of cysless/I344C showing a dramatic increase of the spontaneous ATP-independent gating after MTSET modi-
fication. Before MTSET modification, negligible opening events were observed in the absence of ATP. After MTSET modification, the 
channel activity without ATP is nearly the same as unmodified channel in the presence of ATP. This phenotype can be reversed by DTT. 
For spontaneous ATP-independent openings, the mean open time is 0.38 ± 0.02 s (n = 3) before modification (because these openings 
are rare, we collected events in patches yielding macroscopic currents after ATP was removed as shown in Fig. 10 and performed statis-
tical analysis) and 0.72 ± 0.06 s (n = 5) after modification. Similar results were obtained for cysless/M348C: 0.36 ± 0.03 s (n = 3) before 
and 0.55 ± 0.03 s (n = 3) after modification. (C) Homology model of CFTR using the structure of Sav1866 as a template (adopted from 
Serohijos et al., 2008). The coordinate of the homology model was published by Serohijos et al. (2008). Two horizontal lines depict the 
possible boundaries of the membrane. TMD1 and NBD1 were colored yellow, TMD2 and NBD2 were colored green, and the R domain 
was colored cyan. Part of TM3 (residues 199–217) was removed to show a clear view of TM6 (residues 330–352, blue). S341 and R352 
(red) were represented as sticks.306 TM6 involved in gating motion of CFTR
be readily discerned after MTSET modification. Although 
the trace itself already demonstrates an increase of the 
opening rate after MTSET modification, kinetic analysis 
also reveals that the closing rate is decreased for ATP- 
independent gating (see legend to Fig. 12 for details).
The simplest hypothesis to explain the alterations of 
the stability of both the open and the closed states by 
MTS modification of engineered cysteines on one face 
of TM6 is that residues on this face interact with differ-
ent parts of the CFTR protein in the open and closed 
states. In other words, this part of TM moves relatively 
to other TMs during gating transitions. Indeed, much 
previous work has suggested interactions of the cyto-
plasmic part of TM6 with other TMs. For example, bio-
chemical studies demonstrated that both M348C and 
T351C can be cross-linked to T1142C in TM12 (Chen   
et al. 2004). R347 was shown to form a salt bridge with 
D924 in TM8 (Cotten and Welsh, 1999). More recently, 
it has also been suggested that R352 interacts with D993 
in TM9 through an electrostatic mechanism (Cui et al., 
2008; Jordan et al., 2008). In light of these reports, it 
would not be surprising if replacing hydrophobic side 
chains of I344 and M348 with cysteine thiolates plus 
MTSET adducts would alter their interactions. Likewise, 
depositing MTSET and MTSEA, two positively charged 
adducts with different chemical properties, into posi-
tion 352 would lead to differential interactions.
Although more experiments are needed to reveal the 
exact motion of TM6 during the gating cycle, recent 
structural studies provide some clues. By comparing dif-
ferent  crystal  structures  of  ABC  exporters  including 
Sav1866, MsbA, and P-glycoprotein, Gutmann et al. 
(2010)  proposed  rotational  movements  of  the  trans-
membrane helices that form the substrate pathway as a 
molecular mechanism for switching the high-affinity,   
inward-facing conformation to a low-affinity, outward- 
facing  conformation  during  a  transport  cycle.  If  this 
proposition is correct, the same mechanism may be used 
by members of ABCC subfamily that similarly export hy-
drophobic cargos out of the cell. Perhaps, as a member 
of the ABCC subfamily, CFTR may adopt this molecular 
motion for opening and closing of the gate.
Roles of TM6 in the formation of the CFTR pore
Although  the  current  study  provides  compelling  evi-
dence for the involvement of TM6 in gating motion, its 
role on anion permeation is less straightforward. On the 
one hand, several of the current results are consistent 
with the idea that TM6 lines the pore. First, similar to 
previous findings (Tabcharani et al., 1993; McDonough 
et al., 1994; Linsdell et al., 1998, 2000; Smith et al., 2001; 
Cui et al., 2008), mutations at seven positions (Fig. 2) de-
crease the single-channel amplitude. Second, the potency 
to an open-channel blocker, glibenclamide, is reduced 
by the charge-neutralizing mutation R352C (also see 
Cui et al., 2008), but was restored by charge-restoring 
adducts. These results imply that this face of helix moves 
during the gating cycle.
Previous work has suggested that CFTR gating in-
volves the movement of residues at the external part of 
TM6 (Zhang et al., 2005; Beck et al., 2008; Fatehi and 
Linsdell, 2008). However, that conclusion is mostly in-
ferred from state-dependent accessibility of introduced 
cysteines. Some explored this issue by manipulating the 
NBDs (Zhang et al., 2005; Beck et al., 2008), and others 
by comparing the pre- and post-phosphorylation states 
(Fatehi and Linsdell, 2008). These studies, however, do 
not provide insights into the exact motion of TM6 dur-
ing the gating cycle. In fact, the change in accessibility 
does not necessarily indicate a movement of the region 
with engineered cysteines. For example, in Shaker potas-
sium channel, it has been shown that state-dependent 
accessibility of several introduced cysteines is caused by 
gating motion in regions different from the location 
with the introduced cysteines, which may remain rela-
tively static during the gating conformational changes 
(Liu et al., 1997). Here, based on the change in the 
open  time  and  the  closed  time  between  unmodified 
and modified channels, we propose that part of TM6 
(residues 344–352) is directly involved in the gating mo-
tion of CFTR. It should be noted that only the relative 
motion of TM6 to other parts of the CFTR protein can 
be inferred here.
Gating  conformational  changes  in  the  TMDs  are 
likely driven by the dimer formation of the NBDs upon 
ATP binding and subsequent partial separation of the 
NBD dimer induced by ATP hydrolysis (Vergani et al., 
2005; Zhou et al., 2006; Tsai et al., 2009, 2010). And   
recent statistical analysis of gating kinetics has shown 
that the gating cycle of the pore is tightly coupled to the 
ATP catalytic cycle in WT CFTR (Csanády et al., 2010). 
However, our results showing drastic alterations in gat-
ing kinetics caused by modulating TM6 in the TMDs 
(e.g., a long-lasting opening on the order of tens of sec-
onds with the MTSET-modified cysless/I344C channel) 
raise the possibility that gating motion in the TMDs can 
also  affect  ATP  binding  and  hydrolysis  in  the  NBDs 
(compare Kogan et al. 2001), a subject worth more ex-
tensive future explorations.
If the MTSET adducts deposited at positions 344 and 
348 indeed stabilize the open state and destabilize the 
closed state, one would predict that even in the absence 
of ATP, there will be more opening events after MTSET 
modification. In fact, our data show that the Po of spon-
taneous gating in the absence of ATP (Bompadre et al., 
2007; Wang et al., 2010) is visibly increased by MTSET 
modification (Figs. 4 D and 12 B; Po is 0.19 ± 0.04, n = 5 
for cysless/M348C, and 0.63 ± 0.03, n = 4 for cysless/
I344C).  The  single-channel  trace  of  cysless/I344C  in 
Fig. 12 B illustrates a negligible ATP-independent gat-
ing  before  MTSET  modification,  whereas  frequent 
opening and closing events in the absence of ATP can   Bai et al. 307
Locher, 2006) as a template. At first glance, it seems   
reassuring that all six positive hits identified in the 
present study nicely snuggle on the surface of the ion 
permeation pathway in the homology models proposed 
by Serohijos et al. (2008) and Alexander et al. (2009). 
We  are  cautious  here  to  point  out  several  potential 
problems with these models. First, not surprisingly, all 
of these models show an outward-facing conformation 
of TMDs with the same gap separating two membrane-
spanning  halves  of  the  molecule  as  seen  in  Sav1866 
(Fig. 12 C). For Sav1866, this gap on the same plane as 
the outer leaflet of the membrane bilayer is probably 
essential for its function as a “vacuum cleaner” that moves 
hydrophobic substrates across the bilayer (see Gutmann 
et al., 2010 for details). In contrast, this space that is 
freely connected to the lipid bilayer is conceptually in-
compatible with the function of CFTR as an ion chan-
nel because ions and lipids simply don’t mix. An ion 
channel pore needs to be guarded against the invasion 
of membrane lipids. Second, these outward-facing struc-
tural models show a pore widely open toward the exter-
nal end with no apparent constriction beyond residue 
352 (Fig. 12 C). This appears to be in conflict with the 
experimental data showing the existence of a barrier 
(residues 338–341) for the bulky MTS reagents. Third, 
close inspection of the pore from the cytoplasmic end of 
the modeled structures fails to observe a wide pore en-
trance that allows trespass by large organic anions that 
block  the  channel  from  the  intracellular  side  of  the   
membrane. Lastly, the idea that TM6 needs to inter-
act with different parts of CFTR during gating transi-
tions means that at least I344, M348, and R352 may not 
line the pore all the time. Thus, at this juncture, more 
studies are needed to elucidate the architecture of the 
CFTR pore.
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